Given the significant role of HDACs in tumor progression, metastasis, and drug resistance, we hypothesize that targeting HDAC4 and HDAC8 will enhance doxo sensitivity, promote apoptosis, and inhibit tumor growth. This evidence concerns the gene HDAC4 and neoplasm.